Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices 34875 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

delegated to the Assistant Administrator 

of the DEA Diversion Control Division 

(‘‘Assistant Administrator’’) pursuant to 

section 7 of 28 CFR part 0, appendix to 

subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 

18, 2018, Catalent Pharma Solutions, 

LLC, 3031 Red Lion Road, Philadelphia, 

Pennsylvania 19114, applied to be 

registered as an importer of the 

following basic class of controlled 

substance: 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

The company plans to import finished 

dosage unit products containing gammahydroxybutyric acid for clinical trials, 

research, and analytical activities. 

Dated: July 12, 2018 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15719 Filed 7–20–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: VHG Labs DBA LGC 

Standards 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 22, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 22, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on April 

13, 2018, VHG Labs DBA LGC 

Standards, 3 Perimeter Road, 

Manchaster NH 03103 applied to be 

registered as an importer of the 

following basic classes of controlled 

substances: 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3-FMC) ...................................................................................................................... 1233 I 

Cathinone ................................................................................................................................................................ 1235 I 

Methcathinone ......................................................................................................................................................... 1237 I 

4-Fluoro-N-methylcathinone (4-FMC) ...................................................................................................................... 1238 I 

Pentedrone (a-methylaminovalerophenone) ........................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................ 1248 I 

4-Methyl-N-ethylcathinone (4-MEC) ........................................................................................................................ 1249 I 

Naphyrone ............................................................................................................................................................... 1258 I 

N-Ethylamphetamine ............................................................................................................................................... 1475 I 

4-Methylaminorex (cis isomer) ................................................................................................................................ 1590 I 

Methaqualone .......................................................................................................................................................... 2565 I 

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ........................................................................................... 6250 I 

SR-18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................ 7008 I 

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ...................................................... 7048 I 

JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ........................................................................................... 7081 I 

SR-19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................. 7104 I 

JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... 7118 I 

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................. 7122 I 

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .......................................................... 7144 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................... 7201 I 

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................. 7203 I 

Ibogaine ................................................................................................................................................................... 7260 I 

Lysergic acid diethylamide ...................................................................................................................................... 7315 I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ........................................................................................ 7348 I 

Marihuana ................................................................................................................................................................ 7360 I 

Mescaline ................................................................................................................................................................ 7381 I 

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) .................................................................................... 7385 I 


amozie on DSK3GDR082PROD with NOTICES1
34876 Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices 

Controlled substance Drug code Schedule 

4-Bromo-2,5-dimethoxyamphetamine ..................................................................................................................... 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 7392 I 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................. 7398 I 

3,4-Methylenedioxyamphetamine ............................................................................................................................ 7400 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine .................................................................................................................... 7405 I 

4-Methoxyamphetamine .......................................................................................................................................... 7411 I 

5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................ 7431 I 

Alpha-methyltryptamine ........................................................................................................................................... 7432 I 

Bufotenine ............................................................................................................................................................... 7433 I 

Dimethyltryptamine .................................................................................................................................................. 7435 I 

Psilocyn ................................................................................................................................................................... 7438 I 

N-Benzylpiperazine ................................................................................................................................................. 7493 I 

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ............................................................................................. 7498 I 

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) ............................................................................................ 7509 I 

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ................................................................................................ 7518 I 

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ........................................................................................... 7519 I 

MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................... 7535 I 

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) ............................................. 7537 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................. 7540 I 

Butylone ................................................................................................................................................................... 7541 I 

Pentylone ................................................................................................................................................................. 7542 I 

alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................ 7545 I 

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ............................................................................................ 7694 I 

Codeine-N-oxide ...................................................................................................................................................... 9053 I 

Desomorphine ......................................................................................................................................................... 9055 I 

Dihydromorphine ..................................................................................................................................................... 9145 I 

Heroin ...................................................................................................................................................................... 9200 I 

Morphine-N-oxide .................................................................................................................................................... 9307 I 

Normorphine ............................................................................................................................................................ 9313 I 

Pholcodine ............................................................................................................................................................... 9314 I 

Dipipanone .............................................................................................................................................................. 9622 I 

Properidine .............................................................................................................................................................. 9644 I 

Tilidine ..................................................................................................................................................................... 9750 I 

Alpha-methylfentanyl ............................................................................................................................................... 9814 I 

Methamphetamine ................................................................................................................................................... 1105 II 

Phenmetrazine ........................................................................................................................................................ 1631 II 

Amobarbital ............................................................................................................................................................. 2125 II 

Pentobarbital ........................................................................................................................................................... 2270 II 

Secobarbital ............................................................................................................................................................. 2315 II 

Glutethimide ............................................................................................................................................................ 2550 II 

Phencyclidine .......................................................................................................................................................... 7471 II 

Phenylacetone ......................................................................................................................................................... 8501 II 

Alphaprodine ........................................................................................................................................................... 9010 II 

Dihydrocodeine ........................................................................................................................................................ 9120 II 

Diphenoxylate .......................................................................................................................................................... 9170 II 

Ecgonine .................................................................................................................................................................. 9180 II 

Ethylmorphine .......................................................................................................................................................... 9190 II 

Levorphanol ............................................................................................................................................................. 9220 II 

Isomethadone .......................................................................................................................................................... 9226 II 

Meperidine ............................................................................................................................................................... 9230 II 

Meperidine intermediate-B ...................................................................................................................................... 9233 II 

Meperidine intermediate-C ...................................................................................................................................... 9234 II 

Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II 

14-Hydroxmorphone ................................................................................................................................................ 9665 II 

Noroxymorphone ..................................................................................................................................................... 9668 II 

Remifentanil ............................................................................................................................................................. 9739 II 

Sufentanil ................................................................................................................................................................. 9740 II 

The company plans to import 

analytical reference standards for 

distribution to its customers for research 

and analytical purposes. Placement of 

these drug codes onto the company’s 

registration does not translate into 

automatic approval of subsequent 

permit applications to import controlled 

substance. Approval of permit 

applications will occur only when the 

registrant’s business activity is 

consistent with what is authorized 

under 21 U.S.C. 952(a) (2). 

Authorization will not extend to the 

import of FDA approved or nonapproved finished dosage forms for 

commercial sale. 

Dated: July 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15721 Filed 7–20–18; 8:45 am] 

BILLING CODE 4410–09–P 


amozie on DSK3GDR082PROD with NOTICES1